Home › Funds › Atle Fund Management AB › IRON

Atle Fund Management AB position in IRON

Disc Medicine, Inc. · Health Care

Atle Fund Management AB reported holding 43,682 shares of IRON (Disc Medicine, Inc.) in its Q3 2026 13F filing — a position valued at US$2.9M, representing 0.77% of its reported portfolio and ranking #35 among its reported holdings. Atle Fund Management AB has disclosed IRON holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)43.68K sh
Reported value held$2.86M
Portfolio Weight0.77%
First reportedQ2 2025
Last changeHold
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How Atle Fund Management AB's IRON position evolved

Atle Fund Management AB first disclosed a stake in IRON in Q2 2025 at 24,652 shares (US$1.3M). The position peaked in Q4 2025 at 47,967 shares, worth US$3.8M. Across 6 filings, Atle Fund Management AB increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 43,682 shares valued at US$2.9M. Notable position changes include a 85% increase in Q3 2025 (shares rose 20% over the following quarter), a 124% increase in Q1 2026 (shares rose 14% over the following quarter), a 59% trim in Q2 2026 (shares fell 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 24.65K $1.31M New
Q3 2025 45.69K $320.53K Add
Q4 2025 47.97K $3.81M Add
Q1 2026 107.25K $3.19M Add
Q2 2026 43.68K $3.19M Reduce
Q3 2026 43.68K $2.86M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IRON and 13F data

IRON (Disc Medicine, Inc.) is a Health Care company. 42 other funds we track also report a position in IRON — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$179.2M), Vestal Point Capital, LP (US$113.4M), Atlas Venture Life Science Advisors, LLC (US$110.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IRON

All IRON fund holders →

FAQ

How long has Atle Fund Management AB held IRON?

Atle Fund Management AB has disclosed IRON holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is Atle Fund Management AB's current position in IRON?

As of Q3 2026, Atle Fund Management AB holds 43.68K shares of IRON (Disc Medicine, Inc.), valued at $2.86M, representing 0.77% of its reported portfolio and ranking #35.

Has Atle Fund Management AB been buying or selling IRON?

In the latest 13F filing (Q3 2026), Atle Fund Management AB held unchanged its position in IRON. The position peaked in Q4 2025 at 47.97K shares.

Which other funds hold IRON?

Other major institutional holders of IRON include RA CAPITAL MANAGEMENT, L.P., Vestal Point Capital, LP, Atlas Venture Life Science Advisors, LLC, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.